XTL BIOPHARMACEUTICALS LTD's ticker is XTLB and the CUSIP is 98386D307. A total of 4 filers reported holding XTL BIOPHARMACEUTICALS LTD in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $108 | -70.2% | 120 | -60.0% | 0.00% | – |
| Q4 2022 | $363 | -81.8% | 300 | -63.1% | 0.00% | – |
| Q1 2022 | $2,000 | – | 812 | +427.3% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 154 | -94.7% | 0.00% | – |
| Q3 2021 | $13,000 | +8.3% | 2,898 | -17.8% | 0.00% | – |
| Q1 2021 | $12,000 | +500.0% | 3,524 | +240.2% | 0.00% | – |
| Q3 2020 | $2,000 | 0.0% | 1,036 | -15.4% | 0.00% | – |
| Q4 2019 | $2,000 | -60.0% | 1,224 | -63.2% | 0.00% | – |
| Q3 2019 | $5,000 | -28.6% | 3,328 | -5.7% | 0.00% | – |
| Q2 2019 | $7,000 | -53.3% | 3,528 | -44.2% | 0.00% | – |
| Q1 2019 | $15,000 | +25.0% | 6,328 | -5.1% | 0.00% | – |
| Q4 2018 | $12,000 | -14.3% | 6,671 | +3.3% | 0.00% | – |
| Q3 2018 | $14,000 | +1300.0% | 6,455 | +832.8% | 0.00% | – |
| Q2 2018 | $1,000 | -50.0% | 692 | -38.7% | 0.00% | – |
| Q1 2018 | $2,000 | 0.0% | 1,129 | +60.6% | 0.00% | – |
| Q4 2017 | $2,000 | -71.4% | 703 | -76.9% | 0.00% | – |
| Q3 2017 | $7,000 | -86.5% | 3,040 | -81.4% | 0.00% | – |
| Q2 2017 | $52,000 | +271.4% | 16,309 | +206.6% | 0.00% | – |
| Q1 2017 | $14,000 | – | 5,320 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Noked Capital LTD | 198,888 | $794,000 | 0.20% |
| Noked Israel Ltd | 198,888 | $794,000 | 0.20% |
| SteelPeak Wealth, LLC | 11,671 | $47,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MORGAN STANLEY | 54,064 | $216,000 | 0.00% |
| Renaissance Technologies | 37,187 | $148,000 | 0.00% |